A Duke-led study suggests bedside retinal scans of very preterm infants may predict motor and cognitive delays by age two.

UT Austin researchers are installing ultrasonic sensors and refining seismic models to spot canister damage before it spreads as Texas invests $350M in advanced nuclear.

At Snowflake Summit, the company’s HR chief said candidates should be 'AI curious' as Snowflake folds agentic tools into daily work and hiring.

The FTC is requiring Ascension to divest seven ambulatory surgery centers in five metros before its $3.9B AmSurg acquisition can close.

FDA found Bacillus cereus and other quality lapses at Medline's Waukegan drug plant; the agency ordered independent risk assessments and remediation timelines.

An early Penn Medicine trial suggests CAR‑T immunotherapy may be adapted for kidney failure, offering a new path for transplant and fibrosis patients while important safety questions remain.

Arizona Tech Week's debut logged 419 events and more than 18,000 attendees, spotlighting semiconductors, aerospace sponsors and growing university talent.

HydroGraph’s HGRAF shares swung from $0.15 to $8.37 as the company raised C$30M and opened an Austin HQ — even though fiscal‑2025 revenue was just $43,051.

Fail rates jumped across UC Berkeley's intro CS classes this spring as professors point to AI misuse and weak math preparation; faculty are pressing for policy changes.

Microsoft and Mayo Clinic announced a partnership to build a Mayo‑owned AI model for healthcare that will be piloted inside Mayo Clinic’s clinical systems. The model will be trained on de‑identified clinical data and Mayo clinicians' expertise.

Consumer Reports links the AI data‑center buildout to rising household electric bills, with hotspots like Northern Virginia seeing the sharpest increases. Regulators and experts are debating who should pay for new power infrastructure.

Eli Lilly has partnered with Boston’s Ascidian to develop RNA exon‑editing therapies for inherited kidney diseases in a deal that could be worth up to $1.9 billion. The collaboration pairs Ascidian’s platform with Lilly’s Seaport genetic‑medicine hub.

NSF is removing instruments from the Ocean Observatories Initiative, ending key below‑surface measurements off the Pacific Northwest as El Niño approaches.